This study looked at women of reproductive age with diabetes mellitus and their responses to different types of contraceptives including combined contraceptive pills, progestogen-only contraceptive pills, transdermal contraceptive patches, combined vaginal rings, combined injectable contraception, intrauterine devices, progestogen-only injectable contraceptives,  and progestogen-only subnormal implants. The results showed that 35 ug of combination contraceptive pills had no effect on glucose concentrations and insulin secretions. Progestogen-only contraceptive pills were found to produce no complications in women with diabetes mellitus of any age. Across the board, long-active reversible contraceptives (IUD, IUS, progestogen-only injectables, subdermal implants, & vaginal ring) were all found to be safe for use in women with diabetes mellitus. The only complication found was an effect on lipid metabolism. However, the benefits of family planning outweighed the impact on lipid metabolism. Overall, the study found that contraceptives of all types were safe to use in women with diabetes mellitus. The main concern was limiting the dosage value of oral combined contraceptive pills to 35 ug and to consider the needs of each patient in determining which type of contraceptive was most suitable.